| Literature DB >> 21680622 |
Martin J Spink1, Hylton B Menz, Mohammad R Fotoohabadi, Elin Wee, Karl B Landorf, Keith D Hill, Stephen R Lord.
Abstract
OBJECTIVE: To determine the effectiveness of a multifaceted podiatry intervention in preventing falls in community dwelling older people with disabling foot pain.Entities:
Mesh:
Year: 2011 PMID: 21680622 PMCID: PMC3116775 DOI: 10.1136/bmj.d3411
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Flow of participants through study
Baseline characteristics of participants in intervention (multifaceted podiatry programme) and control (routine podiatry care) groups. Values are numbers (percentages) unless stated otherwise
| Characteristics | Podiatry intervention group (n=153) | Control group (n=152) |
|---|---|---|
| Mean (SD) age (years) | 74.2 (6.0) | 73.6 (5.7) |
| Women | 106 (69) | 105 (69) |
| Living alone | 50 (33) | 53 (35) |
| Mean (SD) body mass index | 29.4 (5.0) | 29.7 (5.4) |
| Medical conditions: | ||
| Diabetes | 23 (15) | 31 (20) |
| Stroke | 10 (7) | 12 (8) |
| Heart disease | 34 (22) | 31 (21) |
| Osteoarthritis | 106 (69) | 90 (59) |
| Rheumatoid arthritis | 12 (8) | 19 (13) |
| ≥4 drugs | 91 (60) | 88 (58) |
| Fallen in past 12 months | 82 (57) | 83 (55) |
| ≥2 falls in previous year | 48 (32) | 45 (30) |
| Physical activity: | ||
| Mean (SD) incidental activity (hrs/week) | 33.9 (15.2) | 36.0 (13.2) |
| Mean (SD) planned activity (hrs/week) | 3.3 (3.5) | 3.9 (4.3) |
| Mean (SD) duration of foot pain (years) | 6.1 (7.5) | 7.7 (8.1) |
| Location of foot pain: | ||
| Heel | 80 (52.6) | 61 (39.9) |
| Arch | 80 (52.6) | 67 (43.8) |
| Forefoot | 92 (60.5) | 97 (63.4) |
| Toes | 102 (67.1) | 109 (71.2) |
Falls rate and proportions of fallers and multiple fallers by treatment group over 12 month trial period. Values are numbers (percentages) unless stated otherwise
| Outcome measure | Podiatry intervention group (n=153) | Control group (n=152) | Falls risk ratio (95% CI) | P value |
|---|---|---|---|---|
| Mean (range) falls per participant | 0.67 (0-6) | 1.06 (0-15) | 0.64 (0.45 to 0.91)* | 0.01 |
| ≥1 falls | 64 (42) | 75 (49) | 0.85 (0.66 to 1.08)† | 0.19 |
| ≥2 falls | 21 (14) | 33 (22) | 0.63 (0.38 to 1.04)† | 0.07 |
*Incidence rate ratio.
†Relative risk.
Secondary outcome measures at baseline and six month follow-up. Values are means (standard deviations) unless otherwise stated
| Variables | Podiatry intervention group (n=153) | Control group (n=152) | Adjusted mean difference (95% CI)† | P value | |||
|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | ||||
| Strength (Newtons): | |||||||
| Ankle dorsiflexion | 154.72 (41.65) | 171.29 (45.54) | 152.11 (46.11) | 161.74 (44.57) | 7.60 (−0.41 to 15.62) | 0.063 | |
| Ankle plantarflexion | 206.17 (55.29) | 229.05 (51.18) | 199.01 (51.72) | 220.63 (50.97) | 3.94 (−5.75 to 13.63) | 0.423 | |
| Ankle inversion | 100.73 (34.91) | 106.15 (34.03) | 102.90 (34.66) | 102.43 (31.64) | 5.33 (0.53 to 10.13) | 0.030 | |
| Ankle eversion | 97.85 (29.08) | 107.76 (28.19) | 99.18 (30.60) | 100.99 (28.50) | 7.69 (2.87 to 12.51) | 0.002* | |
| Lesser toe plantarflexion | 68.00 (25.06) | 74.15 (29.94) | 67.95 (27.18) | 70.09 (27.09) | 4.01 (−1.14 to 9.17) | 0.125 | |
| Hallux plantarflexion | 68.23 (26.97) | 69.62 (30.08) | 68.95 (27.98) | 69.79 (28.00) | 0.43 (−4.00 to 4.87) | 0.847 | |
| Range of motion (degrees): | |||||||
| Ankle dorsiflexion, knee extended | 30.91 (5.60) | 32.81 (6.69) | 30.41 (6.32) | 31.06 (6.10) | 1.37 (0.34 to 2.41) | 0.009* | |
| Ankle dorsiflexion, knee flexed | 39.96 (7.07) | 40.70 (7.64) | 38.69 (6.81) | 38.60 (6.00) | 1.05 (0.18 to 1.92) | 0.018* | |
| Ankle inversion/eversion | 32.56 (9.51) | 36.12 (11.74) | 32.63 (9.65) | 33.51 (9.84) | 2.66 (0.65 to 4.66) | 0.010* | |
| 1st MTPJ dorsiflexion | 72.85 (18.76) | 76.32 (18.41) | 75.83 (16.71) | 78.98 (15.59) | −0.18 (−2.27 to 1.91) | 0.865 | |
| Balance tests: | |||||||
| Postural sway on floor, barefoot (mm²) | 137.82 (205.87) | 94.43 (38.21) | 114.37 (121.06) | 119.58 (125.19) | −28.63 (−49.08 to −8.17) | 0.003* | |
| Postural sway on foam, barefoot (mm²) | 215.87 (203.26) | 163.92 (99.14) | 238.03 (235.39) | 221.58 (321.16) | −51.02 (−103.49 to 1.44) | 0.083 | |
| Postural sway on floor, shod (mm²) | 114.66 (75.67) | 104.65 (38.81) | 120.62 (76.03) | 118.26 (118.66) | −10.95 (−29.76 to 7.87) | 0.478 | |
| Postural sway on foam, shod (mm²) | 201.49 (148.90) | 181.07 (119.10) | 224.15 (182.76) | 191.68 (194.99) | −2.96 (−34.42 to 31.50) | 0.888 | |
| Maximum balance range, barefoot (mm) | 116.16 (33.17) | 132.99(30.74) | 108.37 (28.41) | 123.88 (26.34) | 4.00 (−1.21 to 9.20) | 0.131 | |
| Maximum balance range, shod (mm) | 125.02 (27.74) | 140.29(27.47) | 122.48 (27.18) | 127.80 (28.685) | 10.83 (5.48 to 16.19) | <0.001* | |
| Coordinated stability, barefoot (errors) | 9.20 (8.13) | 8.11 (7.74) | 10.18 (8.40) | 9.27 (8.06) | −0.50 (−1.74 to 0.74) | 0.051 | |
| Coordinated stability, shod (errors) | 7.78 (7.17) | 7.15 (6.63) | 8.96 (7.80) | 7.42 (6.78) | 0.48 (−0.58 to 1.54) | 0.421 | |
| Lateral stability, barefoot (mm) | 58.42 (40.79) | 52.79 (37.66) | 63.64 (44.91) | 53.58 (40.14) | 1.54 (−6.71 to 9.80) | 0.889 | |
| Lateral stability, shod (mm) | 50.09 (37.27) | 49.54 (32.02) | 48.78 (32.83) | 48.55 (29.43) | −0.52 (−6.07 to 7.11) | 0.918 | |
| Functional ability: | |||||||
| Alternate step test (s) | 11.95 (4.39) | 10.30 (3.94) | 11.56 (3.84) | 10.54 (3.93) | −0.53 (−1.12 to 0.07) | 0.038 | |
| Six metre walk (m/s) | 0.95 (0.20) | 0.98 (0.20) | 0.96 (0.20) | 0.99 (0.21) | 0.00 (−0.03 to 0.03) | 0.959 | |
| Sit to stand (s) | 13.41 (4.16) | 12.78 (6.58) | 13.37 (4.56) | 12.45 (5.81) | 0.29 (−0.79 to 1.38) | 0.348 | |
| Falls risk: | |||||||
| PPA total score | 1.28 (0.93) | 0.82 (0.93) | 1.38 (1.00) | 1.05 (0.99) | −0.17 (−0.35 to 0.01) | 0.059 | |
| Foot pain and disability: | |||||||
| MFPDI, pain subscale | 3.86 (1.95) | 2.76 (2.17) | 4.03 (2.04) | 3.27 (2.50) | −0.42 (−0.91 to 0.08) | 0.101 | |
| MFPDI, function subscale | 8.01 (4.39) | 5.67 (4.59) | 8.04 (4.40) | 6.23 (4.86) | −0.55 (−1.49 to 0.40) | 0.257 | |
| Fear of falling: | |||||||
| Falls efficacy scale international | 13.08 (3.99) | 12.00 (4.41) | 13.38 (4.51) | 12.50 (3.94) | −0.31 (−1.06 to 0.44) | 0.419 | |
| Health related quality of life: | |||||||
| SF-12 physical score | 38.77 (10.08) | 40.01 (9.85) | 39.83 (9.28) | 39.49 (10.75) | 1.33 (−0.40 to 3.06) | 0.131 | |
| SF-12 mental score | 50.16 (11.14) | 50.51 (10.47) | 49.09 (10.44) | 50.08 (9.43) | −0.14 (−2.00 to 1.71) | 0.881 | |
PPA=physiological profile assessment; MTPJ=metatarsophalangeal joint; MFPDI=Manchester foot pain and disability index, SF-12=short form 12 health survey.
*P<0.05 after retrospective testing using Hochberg procedure.
†Adjusted for baseline score and intervention group using analysis of covariance.